Investigational Site Number : 7100014

Pretoria 0157

0 studies enrolling now · 2 studies all time

What they study most

Chronic Kidney Diseases, Dermatitis Atopic, Heart Failure, Type 2 Diabetes Mellitus

Studies at this site

• Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis — Running, not enrolling
• Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk — Stopped early